Nestin as a marker of cancer stem cells

Cancer Science

Volumn 106, Issue 7, 2015, Pages 803-811

  Neradil, Jakub ^a,b   Veselska, Renata ^a,c  

^a MASARYK UNIVERSITY   (Czech Republic)

^b MASARYK MEMORIAL CANCER INSTITUTE   (Czech Republic)

^c UNIVERSITY HOSPITAL BRNO   (Czech Republic)

Author keywords

Cancer stem cells; Cytoskeleton; Intermediate filaments; Nestin; Tumor markers

Indexed keywords

BETA CATENIN; BIOLOGICAL MARKER; CD133 ANTIGEN; NESTIN; TRANSCRIPTION FACTOR SOX2; NES PROTEIN, HUMAN; TUMOR MARKER;

CANCER STEM CELL; CARCINOGENICITY; CELL DIFFERENTIATION; CELL INVASION; CELL RENEWAL; CHONDROSARCOMA; EPENDYMOMA; FIBROSARCOMA; GENE EXPRESSION; GENE IDENTIFICATION; GLIOBLASTOMA; GLIOMA; HUMAN; IMMUNODETECTION; IN VITRO STUDY; IN VIVO STUDY; MALIGNANT PERIPHERAL NERVE SHEATH TUMOR; MEDULLOBLASTOMA; MEDULLOBLASTOMA CELL LINE; MESENCHYMAL STEM CELL; NEUROECTODERM TUMOR; NEUROGENIC TUMOR; NONHUMAN; OSTEOSARCOMA; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; RHABDOMYOSARCOMA; TRANSFORMED CELL; TUMOR XENOGRAFT; ANIMAL; METABOLISM; NEOPLASM; PATHOLOGY;

ANIMALS; HUMANS; NEOPLASMS; NEOPLASTIC STEM CELLS; NESTIN; TUMOR MARKERS, BIOLOGICAL;

EID: 84936985708     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/cas.12691     Document Type: Review

References (90)

1. Ratajczak MZ. Cancer stem cells - normal stem cells "Jedi" that went over to the "dark side". Folia Histochem Cytobiol 2005; 43: 175-81.
2. Fábián A, Barok M, Vereb G, Szöllosi J. Die hard: are cancer stem cells the Bruce Willises of tumor biology? Cytometry A 2009; 75: 67-74.
3. Friedman GK, Gillespie GY. Cancer stem cells and pediatric solid tumors. Cancers (Basal) 2011; 3: 298-318.
4. Matsuda Y, Hagio M, Ishiwata T. Nestin: a novel angiogenesis marker and possible target for tumor angiogenesis. World J Gastroenterol 2013; 19: 42-8.
5. Clarke MF, Dick JE, Dirks PB et al. Cancer stem cells-perspectives on current status and future directions: AACR Workshop on cancer stem cells. Cancer Res 2006; 66: 9339-44.
6. Neuzil J, Stantic M, Zobalova R et al. Tumour-initiating cells vs. cancer 'stem' cells and CD133: what's in the name? Biochem Biophys Res Commun 2007; 355: 855-9.
7. McDonald SA, Graham TA, Schier S, Wright NA, Alison MR. Stem cells and solid cancers. Virchows Arch 2009; 455: 1-13.
8. Foreman KE, Rizzo P, Osipo C, Miele L. The Cancer Stem Cell Hypothesis. In: Bagley RG, Teicher BA, eds. Stem Cells and Cancer (Cancer Drug Discovery). New York: Humana Press, 2009; 3-14.
9. Alison MR, Lim SM, Nicholson LJ. Cancer stem cells: problems for therapy? J Pathol 2011; 223: 147-61.
10. Hockfield S, McKay RD. Identification of major cell classes in the developing mammalian nervous system. J Neurosci 1985; 5: 3310-28.
11. Lendahl U, Zimmerman LB, McKay RD. CNS stem cells express a new class of intermediate filament protein. Cell 1990; 60: 585-95.
12. Herrmann H, Strelkov SV, Burkhard P, Aebi U. Intermediate filaments: primary determinants of cell architecture and plasticity. J Clin Invest 2009; 119: 1772-83.
13. Leduc C, Etienne-Manneville S. Intermediate filaments in cell migration and invasion: the unusual suspects. Curr Opin Cell Biol 2015; 32: 102-12.
14. Dey P, Togra J, Mitra S. Intermediate filament: structure, function, and applications in cytology. Diagn Cytopathol 2014; 42: 628-35.
15. Cheng L, Jin Z, Liu L et al. Characterization and promoter analysis of the mouse nestin gene. FEBS Lett 2004; 565: 195-202.
16. Zimmerman L, Parr B, Lendahl U et al. Independent regulatory elements in the nestin gene direct transgene expression to neural stem cells or muscle precursors. Neuron 1994; 12: 11-24.
17. Zhong H, Jin Z, Chen Y et al. First intron of nestin gene regulates its expression during C2C12 myoblast differentiation. Acta Biochim Biophys Sin 2008; 40: 526-32.
18. Michalczyk K, Ziman M. Nestin structure and predicted function in cellular cytoskeletal organisation. Histol Histopathol 2005; 20: 665-71.
19. Tanaka S, Kamachi Y, Tanouchi A, Hamada H, Jing N, Kondoh H. Interplay of SOX and POU factors in regulation of the Nestin gene in neural primordial cells. Mol Cell Biol 2004; 24: 8834-46.
20. Han DW, Do JT, Araúzo-Bravo MJ et al. Epigenetic hierarchy governing Nestin expression. Stem Cells 2009; 27: 1088-97.
21. Messam CA, Hou J, Major EO. Coexpression of nestin in neural and glial cells in the developing human CNS defined by a human-specific anti-nestin antibody. Exp Neurol 2000; 161: 585-96.
22. Herrmann H, Aebi U. Intermediate filaments and their associates: multi-talented structural elements specifying cytoarchitecture and cytodynamics. Curr Opin Cell Biol 2000; 12: 79-90.
23. Wiese C, Rolletschek A, Kania G et al. Nestin expression - a property of multi-lineage progenitor cells? Cell Mol Life Sci 2004; 61: 2510-22.
24. Krupkova O Jr, Loja T, Zambo I, Veselska R. Nestin expression in human tumors and tumor cell lines. Neoplasma 2010; 57: 291-8.
25. Ishiwata T, Matsuda Y, Naito Z. Nestin in gastrointestinal and other cancers: effects on cells and tumor angiogenesis. World J Gastroenterol 2011; 17: 409-18.
26. Gilyarov AV. Nestin in central nervous system cells. Neurosci Behav Physiol 2008; 38: 165-9.
27. Calderone A. Nestin+ cells and healing the infarcted heart. Am J Physiol Heart Circ Physiol 2012; 302: H1-9.
28. Daniel C, Albrecht H, Lüdke A, Hugo C. Nestin expression in repopulating mesangial cells promotes their proliferation. Lab Invest 2008; 88: 387-97.
29. Singh SK, Clarke ID, Terasaki M et al. Identification of a cancer stem cell in human brain tumors. Cancer Res 2003; 63: 5821-8.
30. Veselska R, Skoda J, Neradil J. Detection of cancer stem cell markers in sarcomas. Klin Onkol 2012; 25: 2S16-20.
31. Sterlacci W, Savic S, Fiegl M, Obermann E, Tzankov A. Putative stem cell markers in non-small-cell lung cancer: a clinicopathologic characterization. J Thorac Oncol 2014; 9: 41-9.
32. Ehrmann J, Kolár Z, Mokry J. Nestin as a diagnostic and prognostic marker: immunohistochemical analysis of its expression in different tumours. J Clin Pathol 2005; 58: 222-3.
33. Kolar Z, Ehrmann J Jr, Turashvili G, Bouchal J, Mokry J. A novel myoepithelial/progenitor cell marker in the breast? Virchows Arch 2007; 450: 607-9.
34. He QZ, Luo XZ, Zhou Q et al. Expression of nestin in ovarian serous cancer and its clinicopathologic significance. Eur Rev Med Pharmacol Sci 2013; 17: 2896-901.
35. Parfitt JR, McLean CA, Joseph MG, Streutker CJ, Al-Haddad S, Driman DK. Granular cell tumours of the gastrointestinal tract: expression of nestin and clinicopathological evaluation of 11 patients. Histopathology 2006; 48: 424-30.
36. Sakurada K, Saino M, Mouri W, Sato A, Kitanaka C, Kayama T. Nestin expression in central nervous system germ cell tumors. Neurosurg Rev 2008; 31: 173-6.
37. Zambo I, Hermanova M, Adamkova Krakorova D et al. Nestin expression in high-grade osteosarcomas and its clinical significance. Oncol Rep 2012; 27: 1592-8.
38. Nambirajan A, Sharma MC, Gupta RK, Suri V, Singh M, Sarkar C. Study of stem cell marker nestin and its correlation with vascular endothelial growth factor and microvascular density in ependymomas. Neuropathol Appl Neurobiol 2014; 40: 714-25.
39. Sabet MN, Rakhshan A, Erfani E, Madjd Z. Co-expression of putative cancer stem cell markers, CD133 and nestin, in skin tumors. Asian Pac J Cancer Prev 2014; 15: 8161-9.
40. Lenz J, Karasek P, Jarkovsky J et al. Clinicopathological correlations of nestin expression in surgically resectable pancreatic cancer including an analysis of perineural invasion. J Gastrointestin Liver Dis 2011; 20: 389-96.
41. Kim HS, Yoo SY, Kim KT, Park JT, Kim HJ, Kim JC. Expression of the stem cell markers CD133 and nestin in pancreatic ductal adenocarcinoma and clinical relevance. Int J Clin Exp Pathol 2012; 5: 754-61.
42. Svachova H, Kryukov F, Kryukova E et al. Nestin expression throughout multistep pathogenesis of multiple myeloma. Br J Haematol 2014; 164: 701-9.
43. Liu S, Otsuyama K, Ma Z et al. Induction of multilineage markers in human myeloma cells and their down-regulation by interleukin 6. Int J Hematol 2007; 85: 49-58.
44. Svachova H, Pour L, Sana J, Kovarova L, Raja KR, Hajek R. Stem cell marker nestin is expressed in plasma cells of multiple myeloma patients. Leuk Res 2011; 35: 1008-13.
45. Singh SK, Hawkins C, Clarke ID et al. Identification of human brain tumour initiating cells. Nature 2004; 432: 396-401.
46. Hussein D, Punjaruk W, Storer LC et al. Pediatric brain tumor cancer stem cells: cell cycle dynamics, DNA repair, and etoposide extrusion. Neuro Oncol 2011; 13: 70-83.
47. Zanini C, Ercole E, Mandili G et al. Medullospheres from DAOY, UW228 and ONS-76 cells: increased stem cell population and proteomic modifications. PLoS One 2013; 8: e63748.
48. Iacopino F, Angelucci C, Piacentini R et al. Isolation of cancer stem cells from three human glioblastoma cell lines: characterization of two selected clones. PLoS One 2014; 9: e105166.
49. Spyra M, Kluwe L, Hagel C et al. Cancer stem cell-like cells derived from malignant peripheral nerve sheath tumors. PLoS One 2011; 6: e21099.
50. Zarnescu O, Brehar FM, Bleotu C, Gorgan RM. Co-localization of PCNA, VCAM-1 and caspase-3 with nestin in xenografts derived from human anaplastic astrocytoma and glioblastoma multiforme tumor spheres. Micron 2011; 42: 793-800.
51. Chen J, Li Y, Yu TS et al. A restricted cell population propagates glioblastoma growth after chemotherapy. Nature 2012; 488: 522-6.
52. Wee S, Niklasson M, Marinescu VD et al. Selective calcium sensitivity in immature glioma cancer stem cells. PLoS One 2014; 9: e115698.
53. Sana J, Zambo I, Skoda J et al. CD133 expression and identification of CD133/nestin positive cells in rhabdomyosarcomas and rhabdomyosarcoma cell lines. Anal Cell Pathol 2011; 34: 303-18.
54. Veselska R, Hermanova M, Loja T et al. Nestin expression in osteosarcomas and derivation of nestin/CD133 positive osteosarcoma cell lines. BMC Cancer 2008; 8: 300.
55. Tirino V, Desiderio V, Paino F et al. Human primary bone sarcomas contain CD133 + cancer stem cells displaying high tumorigenicity in vivo. FASEB J 2011; 25: 2022-30.
56. Saini V, Hose CD, Monks A et al. Identification of CBX3 and ABCA5 as putative biomarkers for tumor stem cells in osteosarcoma. PLoS One 2012; 7: e41401.
57. Bapat SA, Mali AM, Koppikar CB, Kurrey NK. Stem and progenitor-like cells contribute to the aggressive behavior of human epithelial ovarian cancer. Cancer Res 2005; 65: 3025-9.
58. Ma L, Lai D, Liu T, Cheng W, Guo L. Cancer stem-like cells can be isolated with drug selection in human ovarian cancer cell line SKOV3. Acta Biochim Biophys Sin 2010; 42: 593-602.
59. He QZ, Luo XZ, Wang K et al. Isolation and characterization of cancer stem cells from high-grade serous ovarian carcinomas. Cell Physiol Biochem 2014; 33: 173-84.
60. Chiou SH, Yu CC, Huang CY et al. Positive correlations of Oct-4 and Nanog in oral cancer stem-like cells and high-grade oral squamous cell carcinoma. Clin Cancer Res 2008; 14: 4085-95.
61. Guzmán-Ramírez N, Völler M, Wetterwald A et al. In vitro propagation and characterization of neoplastic stem/progenitor-like cells from human prostate cancer tissue. Prostate 2009; 69: 1683-93.
62. Liu T, Xu F, Du X et al. Establishment and characterization of multi-drug resistant, prostate carcinoma-initiating stem-like cells from human prostate cancer cell lines 22RV1. Mol Cell Biochem 2010; 340: 265-73.
63. Shi CJ, Gao J, Wang M et al. CD133(+) gallbladder carcinoma cells exhibit self-renewal ability and tumorigenicity. World J Gastroenterol 2011; 17: 2965-71.
64. Janikova M, Skarda J, Dziechciarkova M et al. Identification of CD133+/nestin+ putative cancer stem cells in non-small cell lung cancer. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2010; 154: 321-6.
65. Wang P, Gao Q, Suo Z et al. Identification and characterization of cells with cancer stem cell properties in human primary lung cancer cell lines. PLoS One 2013; 8: e57020.
66. Alamgeer M, Peacock CD, Matsui W, Ganju V, Watkins DN. Cancer stem cells in lung cancer: evidence and controversies. Respirology 2013; 18: 757-64.
67. Takakuwa O, Maeno K, Kunii E et al. Involvement of intermediate filament nestin in cell growth of small-cell lung cancer. Lung Cancer 2013; 81: 174-9.
68. Li Y, Wang L, Pappan L, Galliher-Beckley A, Shi J. IL-1β promotes stemness and invasiveness of colon cancer cells through Zeb1 activation. Mol Cancer 2012; 11: 87.
69. Liu C, Cao X, Zhang Y et al. Co-expression of Oct-4 and Nestin in human breast cancers. Mol Biol Rep 2012; 39: 5875-81.
70. Zhao Z, Lu P, Zhang H et al. Nestin positively regulates the Wnt/β-catenin pathway and the proliferation, survival and invasiveness of breast cancer stem cells. Breast Cancer Res 2014; 16: 408.
71. Apostolou P, Toloudi M, Chatziioannou M, Ioannou E, Papasotiriou I. Cancer stem cells stemness transcription factors expression correlates with breast cancer disease stage. Curr Stem Cell Res Ther 2012; 7: 415-9.
72. Dhingra S, Feng W, Brown RE et al. Clinicopathologic significance of putative stem cell markers, CD44 and nestin, in gastric adenocarcinoma. Int J Clin Exp Pathol 2011; 4: 733-41.
73. Matsuda Y, Yoshimura H, Naito Z, Ishiwata T. The roles and molecular mechanisms of nestin expression in cancer with a focus on pancreatic cancer. J Carcinog Mutagen 2013; S9: 002.
74. Matsuda Y, Yoshimura H, Ueda J, Naito Z, Korc M, Ishiwata T. Nestin delineates pancreatic cancer stem cells in metastatic foci of NOD/Shi-scid IL2Rγ(null) (NOG) mice. Am J Pathol 2014; 184: 674-85.
75. Su HT, Weng CC, Hsiao PJ et al. Stem cell marker nestin is critical for TGF beta1-mediated tumor progression in pancreatic cancer. Mol Cancer Res 2013; 11: 768-79.
76. Wang D, Zhu H, Zhu Y et al. CD133(+)/CD44(+)/Oct4(+)/Nestin(+) stem-like cells isolated from Panc-1 cell line may contribute to multi-resistance and metastasis of pancreatic cancer. Acta Histochem 2013; 115: 349-56.
77. Park D, Xiang AP, Mao FF et al. Nestin is required for the proper self-renewal of neural stem cells. Stem Cells 2010; 28: 2162-71.
78. Shih AH, Holland EC. Notch signaling enhances nestin expression in gliomas. Neoplasia 2006; 8: 1072-82.
79. Thomas SK, Messam CA, Spengler BA, Biedler JL, Ross RA. Nestin is a potential mediator of malignancy in human neuroblastoma cells. J Biol Chem 2004; 279: 27994-9.
80. Cotterman R, Knoepfler PS. N-Myc regulates expression of pluripotency genes in neuroblastoma including lif, klf2, klf4, and lin28b. PLoS One 2009; 4: e5799.
81. Hambardzumyan D, Becher OJ, Holland EC. Cancer stem cells and survival pathways. Cell Cycle 2008; 7: 1371-8.
82. Sahlgren CM, Pallari HM, He T, Chou YH, Goldman RD, Eriksson JE. A nestin scaffold links Cdk5/p35 signaling to oxidant-induced cell death. EMBO J 2006; 25: 4808-19.
83. Veselska R, Kuglik P, Cejpek P et al. Nestin expression in the cell lines derived from glioblastoma multiforme. BMC Cancer 2006; 6: 32.
84. Loja T, Chlapek P, Kuglik P et al. Characterization of a GM7 glioblastoma cell line showing CD133 positivity and both cytoplasmic and nuclear localization of nestin. Oncol Rep 2009; 21: 119-27.
85. Krupkova O Jr, Loja T, Redova M et al. Analysis of nuclear nestin localization in cell lines derived from neurogenic tumors. Tumour Biol 2011; 32: 631-9.
86. Jin X, Jin X, Jung JE, Beck S, Kim H. Cell surface Nestin is a biomarker for glioma stem cells. Biochem Biophys Res Commun 2013; 433: 496-501.
87. Beck S, Jin X, Yin J et al. Identification of a peptide that interacts with Nestin protein expressed in brain cancer stem cells. Biomaterials 2011; 32: 8518-28.
88. Okarvi SM. Peptide-based radiopharmaceuticals and cytotoxic conjugates: potential tools against cancer. Cancer Treat Rev 2008; 34: 13-26.
89. Brown KC. Peptidic tumor targeting agents: the road from phage display peptide selections to clinical applications. Curr Pharm Des 2010; 16: 1040-54.
90. Kraeber-Bodéré F, Rousseau C, Bodet-Milin C et al. Tumor immunotargeting using innovative radionuclides. Int J Mol Sci 2015; 16: 3932-54.